Letters Speeding new antibiotics to market

Sepsis kills, antimicrobial resistance is real

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1935 (Published 14 April 2015) Cite this as: BMJ 2015;350:h1935
  1. Rajkumar Rajendram, consultant in anaesthesia and intensive care1
  1. 1Departments of Anaesthesia and Intensive Care, King Khalid University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
  1. rajkumarrajendram{at}doctors.org.uk

Doshi highlights the danger of speeding new antibiotics to market without adequate testing.1 However, it is dangerous to question the threat from antimicrobial resistance, and such questions must not detract from the urgent need for new antimicrobial agents.

The reduction in mortality from infections worldwide between 1990 and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe